Literature DB >> 27686889

Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery.

Shih-Wei Yang1,2, Wei-Chieh Chao1,2, Yun-Shien Lee3,4, Liang-Che Chang2,5, Tsan-Yu Hsieh2,5, Tai-An Chen1,2, Cheng-Ming Luo6,7.   

Abstract

The aim of this study is to evaluate the treatment outcome and analyze the associated factors of postoperative recurrence in patients who received transoral laser microsurgery for vocal cord leukoplakia. The demographic, histopathological data were retrospectively reviewed and the factors associated with recurrence of vocal leukoplakia after surgery were analyzed statistically. A total of 44 patients, including 36 males and 8 females, with a mean age of 50.4 ± 13.4 years, were enrolled. All the patients received excision of the vocal leukoplakia by carbon dioxide laser (2-4 Watt, ultrapulse mode) under general anesthesia. No patients had malignant transformation after surgery. Postoperative recurrence occurred in 10 patients (22.7 %). Univariate analysis showed that patients who had the habit of cigarette smoking, alcohol drinking, and presence of gastroesophageal reflux disease tended to recur. Among these risk factors, presence of gastroesophageal reflux disease (odds ratio 8.43) was the independent prognostic factor for recurrence using multivariate logistic regression analysis. Carbon dioxide laser excision is effective for treating vocal leukoplakia that is still confined to dysplasia of any degree, with acceptable morbidity. This study suggests that the presence of gastroesophageal reflux disease is the prognostic indicator for postoperative recurrence of vocal leukoplakia. Aggressive treatment of reflux disease for those who have received surgical excision for vocal leukoplakia is indicated.

Entities:  

Keywords:  Alcohol; Carbon dioxide laser; Gastroesophageal reflux disease; Smoking; Transoral laser microsurgery; Vocal cord leukoplakia

Mesh:

Year:  2016        PMID: 27686889     DOI: 10.1007/s10103-016-2078-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  26 in total

Review 1.  Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia.

Authors:  H Mehanna; V Paleri; A Robson; R Wight; T Helliwell
Journal:  Clin Otolaryngol       Date:  2010-06       Impact factor: 2.597

2.  Long-term follow-up of larynx leukoplakia under treatment with retinyl palmitate.

Authors:  W J Issing; R Struck; A Naumann
Journal:  Head Neck       Date:  1996 Nov-Dec       Impact factor: 3.147

3.  Phonatory outcome of 585 nm/pulsed-dye laser in the management of glottic leukoplakia.

Authors:  Young Min Park; Kwang Hee Jo; Hyun Jun Hong; Hong-Shik Choi
Journal:  Auris Nasus Larynx       Date:  2014-06-11       Impact factor: 1.863

4.  Positive therapy of andrographolide in vocal fold leukoplakia.

Authors:  Jue Xu; Tao Xue; Ying Bao; Dong-Hai Wang; Bing-Liang Ma; Chen-Yi Yin; Guang-Hui Yang; Gang Ren; Long-Jiang Lan; Jian-Qiu Wang; Xiao-Lan Zhang; Yu-Qin Zhao
Journal:  Am J Otolaryngol       Date:  2013-12-20       Impact factor: 1.808

5.  A CO2 laser for surgical research.

Authors:  T G Polanyi; H C Bredemeier; T W Davis
Journal:  Med Biol Eng       Date:  1970-11

6.  Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the factors affecting recurrence.

Authors:  Shih-Wei Yang; Chi-Neu Tsai; Yun-Shien Lee; Tai-An Chen
Journal:  J Oral Maxillofac Surg       Date:  2011-03-12       Impact factor: 1.895

7.  Prognostic factors in laryngeal cancer patients submitted to surgical treatment.

Authors:  L P Kowalski; E L Franco; J de Andrade Sobrinho; B V Oliveira; P L Pontes
Journal:  J Surg Oncol       Date:  1991-10       Impact factor: 3.454

Review 8.  Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia.

Authors:  J E Bouquot; D R Gnepp
Journal:  Head Neck       Date:  1991 Nov-Dec       Impact factor: 3.147

9.  Clinical classification and treatment of leukokeratosis of the vocal cords.

Authors:  Li-Jing Ma; Jun Wang; Yang Xiao; Jing-Ying Ye; Wen Xu; Qing-Wen Yang
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

Review 10.  Current review on squamous intraepithelial lesions of the larynx.

Authors:  Nina Gale; Leslie Michaels; Bostjan Luzar; Mario Poljak; Nina Zidar; Janez Fischinger; Antonio Cardesa
Journal:  Histopathology       Date:  2008-08-25       Impact factor: 5.087

View more
  4 in total

1.  Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia.

Authors:  Yi Fang; Yue Yang; Min Chen; Peijie He; Lei Cheng; Jian Chen; Haitao Wu
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-31       Impact factor: 2.503

Review 2.  Management of Laryngeal Dysplasia and Early Invasive Cancer.

Authors:  Candace Hrelec
Journal:  Curr Treat Options Oncol       Date:  2021-08-23

3.  The Variation of Peripheral Inflammatory Markers in Vocal Leukoplakia before and after Recurrence and Canceration.

Authors:  Yi Fang; Min Chen; Yue Yang; Jian Chen; Lei Cheng; Peijie He; Haitao Wu
Journal:  Dis Markers       Date:  2020-08-01       Impact factor: 3.434

4.  A morphological classification for vocal fold leukoplakia.

Authors:  Min Chen; Changjiang Li; Yue Yang; Lei Cheng; Haitao Wu
Journal:  Braz J Otorhinolaryngol       Date:  2018-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.